title: Commentary regarding Double-blind placebo-controlled trial of dapsone in antihistamine refractory chronic idiopathic urticaria by M Morgan, A Cooke, L Rogers, B Adams-Huet, DA Khan. J Allergy Clin Immunol Pract 2:601-606, 2014.
authors: Department of Dermatology, University of Texas Southwestern Medical Center in Dallas, Dallas, Texas.
authors: Kim B
authors: KB
authors: Yancey
mesh_terms: D018926:Anti-Allergic Agents / Q000627:therapeutic use*; D003622:Dapsone / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D014581:Urticaria / Q000188:drug therapy*
chemical_list: D018926:Anti-Allergic Agents; D003622:Dapsone
keywords: dapsone; therapy; urticaria